Retrospective Study of Acute Kidney Injury Incidence in Patients with Newly Diagnosed Acute Promyelocytic Leukemia.
Tadashi KamioHiroshi KoyamaKiyomitsu FukaguchiShuku SatoWataru KamataSatomi OkadaYotaro TamaiPublished in: Journal of blood medicine (2020)
Incidence of AKI development in patients with newly diagnosed APL during induction chemotherapy was approximately 40%. Moreover, patients who developed AKI tended to be administered vancomycin more frequently. Unnecessary use of vancomycin should be avoided in patients with newly diagnosed APL, and using alternative non-nephrotoxic drugs should be considered for patients at risk of AKI.